{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:10:25Z","timestamp":1791421825918,"version":"4.3.3"},"reference-count":134,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020612","name":"Kalinga Institute of Industrial Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023003","name":"NITTE University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbcan.2026.189559","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:40:57Z","timestamp":1770741657000},"page":"189559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Colorectal cancer stem cells in the tumor microenvironmental niche: Mechanistic insights and emerging therapies"],"prefix":"10.1016","volume":"1881","author":[{"given":"Sandhiya","family":"Viswanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuja","family":"Raha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeshna","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189559_bb0005","first-page":"1","article-title":"Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3\/c-MYC axis","volume":"10","author":"Lepore Signorile","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189559_bb0010","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s11605-014-2497-1","article-title":"The colon cancer stem cell microenvironment holds keys to future cancer therapy","volume":"18","author":"Chen","year":"2014","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.bbcan.2026.189559_bb0015","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s13346-020-00863-9","article-title":"Cancer stem cells and strategies for targeted drug delivery","volume":"11","author":"Cao","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bbcan.2026.189559_bb0020","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.3390\/ijms25084140","article-title":"The impact of cancer stem cells in colorectal cancer","volume":"25","author":"Radu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189559_bb0025","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/cancers13051092","article-title":"The role of cancer stem cells in colorectal cancer: from the basics to novel clinical trials","volume":"13","author":"Hervieu","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189559_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60145-9","article-title":"Three-dimensional culture models mimic colon cancer heterogeneity induced by different microenvironments","volume":"10","author":"Kawai","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189559_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113260","article-title":"Colon cancer organoids using monoclonal organoids established in four different lesions of one cancer patient reveal tumor heterogeneity and different real-time responsiveness to anti-cancer drugs","volume":"152","author":"Song","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2026.189559_bb0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3892\/ol.2023.13914","article-title":"Tumor organoid model of colorectal cancer","volume":"26","author":"Yang","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2026.189559_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030376","article-title":"Cancer stem cells\u2014key players in tumor relapse","volume":"13","author":"Marzagalli","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189559_bb0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.stem.2014.11.012","article-title":"De maria, colorectal cancer stem cells: from the crypt to the clinic","volume":"15","author":"Zeuner","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2026.189559_bb0055","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3390\/ijms16022472","article-title":"Promoter hypermethylation of tumor suppressor genes as potential biomarkers in colorectal cancer","volume":"16","author":"Ng","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189559_bb0060","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature21713","article-title":"A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer","volume":"543","author":"de Sousa e Melo","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189559_bb0065","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.3389\/fimmu.2020.02166","article-title":"Tuning cancer fate: tumor microenvironment's role in cancer stem cell quiescence and reawakening","volume":"11","author":"Sistigu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12964-023-01129-w","article-title":"The role of tumor microenvironment on cancer stem cell fate in solid tumors","volume":"21","author":"Razi","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbcan.2026.189559_bb0075","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/onc.2016.57","article-title":"Casal, Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen \u03b11 (VI)","volume":"35","author":"Garc\u00eda-Palmero","year":"2016","journal-title":"Oncogene"},{"issue":"16","key":"10.1016\/j.bbcan.2026.189559_bb0080","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/cells13161334","article-title":"Cancer-associated-fibroblast-mediated paracrine and autocrine SDF-1\/CXCR4 signaling promotes stemness and aggressiveness of colorectal cancers","volume":"13","author":"Chen","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189559_bb0085","first-page":"152","article-title":"The extracellular matrix in tumor progression and metastasis","volume":"107","author":"Eble","year":"2019","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbcan.2026.189559_bb0090","article-title":"Tumor-associated macrophages and CSC niche formation in colorectal cancer","author":"Liu","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189559_bb0095","article-title":"Hypoxia and macrophage act in concert towards a beneficial outcome in colon cancer","author":"Dalen","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189559_bb0100","doi-asserted-by":"crossref","DOI":"10.4252\/wjsc.v16.i12.1110","article-title":"Interplay and therapeutic implications of colorectal cancer stem cells, tumor microenvironment, and gut microbiota","volume":"16","author":"Zhang","year":"2024","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.bbcan.2026.189559_bb0105","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","article-title":"Cancer stem cell\u2013immune cell crosstalk in tumor progression","volume":"21","author":"Bayik","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189559_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.631703","article-title":"Exosomal MicroRNAs mediating crosstalk between cancer cells with cancer-associated fibroblasts and tumor-associated macrophages in the tumor microenvironment","volume":"11","author":"Su","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","article-title":"Pre-metastatic niche: formation, characteristics and therapeutic implication","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189559_bb0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ncb3312","article-title":"Organoids as an in vitro model of human development and disease","volume":"18","author":"Fatehullah","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0125","first-page":"1","article-title":"Rapamycin rescues APC-mutated colon organoid differentiation","author":"Habib","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbcan.2026.189559_bb0130","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41551-022-00863-9","article-title":"Screening for modulators of the cellular composition of gut epithelia via organoid models of intestinal stem cell differentiation","volume":"6","author":"Mead","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bbcan.2026.189559_bb0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41420-025-02567-w","article-title":"Colorectal cancer cell line-derived organoid model with stem cell properties captures the regrowing state of residual cancer cells after neoadjuvant chemotherapy","volume":"11","author":"Nakano","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbcan.2026.189559_bb0140","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nm.4355","article-title":"Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing","volume":"23","author":"Crespo","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189559_bb0145","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/j.gastro.2018.10.031","article-title":"TRIB3 interacts with \u03b2-catenin and TCF4 to increase stem cell features of colorectal cancer stem cells and tumorigenesis","volume":"156","author":"Hua","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2026.189559_bb0150","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3389\/fphar.2017.00949","article-title":"Rimonabant kills colon cancer stem cells without inducing toxicity in normal colon organoids","volume":"8","author":"Fiore","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0155","doi-asserted-by":"crossref","first-page":"v93","DOI":"10.1093\/annonc\/mdq222","article-title":"Advanced colorectal cancer: ESMO clinical practice guidelines for treatment","volume":"21","author":"Van Cutsem","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0160","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/cdd.2014.37","article-title":"Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells","volume":"21","author":"Colak","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbcan.2026.189559_bb0165","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.4161\/15384101.2014.973321","article-title":"Human colonic fibroblasts regulate stemness and chemotherapy resistance of colon cancer stem cells","volume":"15","author":"Colak","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2026.189559_bb0170","article-title":"CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin, iScience","volume":"24","author":"Di Franco","year":"2021"},{"key":"10.1016\/j.bbcan.2026.189559_bb0175","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/aps.2013.56","article-title":"Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs","volume":"34","author":"Rao","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbcan.2026.189559_bb0180","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.csbj.2022.04.037","article-title":"Evaluation of stromal cell infiltration in the tumor microenvironment enable prediction of treatment sensitivity and prognosis in colon cancer","volume":"20","author":"Zhou","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bbcan.2026.189559_bb0185","doi-asserted-by":"crossref","first-page":"28463","DOI":"10.18632\/oncotarget.15307","article-title":"Expression of the cancer stem cell markers ABCG2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189559_bb0190","first-page":"4487","article-title":"C-Myc maintains the self-renewal and chemoresistance properties of colon cancer stem cells","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2026.189559_bb0195","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature22081","article-title":"Visualization and targeting of LGR5+ human colon cancer stem cells","volume":"545","author":"Shimokawa","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189559_bb0200","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41467-019-09898-0","article-title":"MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer","volume":"10","author":"Zhan","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189559_bib626","doi-asserted-by":"crossref","first-page":"e6472","DOI":"10.1590\/1414-431x20176472","article-title":"Exosomes promote cetuximab resistance via the PTEN\/Akt pathway in colon cancer cells","volume":"51","author":"Zhang","year":"2017","journal-title":"Braz. J. Med. Res."},{"key":"10.1016\/j.bbcan.2026.189559_bb0560","first-page":"412","article-title":"Remodeling the tumor microenvironment enhances checkpoint blockade and CSC targeting in colorectal cancer","volume":"15","author":"Nasr","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189559_bib627","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13073-020-0719-6","article-title":"Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer","volume":"12","author":"Zhou","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.bbcan.2026.189559_bb0555","article-title":"Chemokines: humble yet mighty players in the tumour microenvironment","volume":"16","author":"Babykutty","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189559_bib628","doi-asserted-by":"crossref","first-page":"100884","DOI":"10.1016\/j.esmoop.2023.100884","article-title":"Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases","volume":"8","author":"Hecht","year":"2023","journal-title":"ESMO open"},{"key":"10.1016\/j.bbcan.2026.189559_bib629","doi-asserted-by":"crossref","first-page":"8960","DOI":"10.1073\/pnas.2013644117","article-title":"CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response","volume":"117","author":"Biasci","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.bbcan.2026.189559_bib630","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189559_bib631","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s40425-019-0706-x","article-title":"Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors","volume":"7","author":"Bilusic","year":"2019","journal-title":"J. Immunother Cancer"},{"key":"10.1016\/j.bbcan.2026.189559_bib632","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189559_bib633","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41419-025-07855-y","article-title":"Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro\u2010metastatic CMS4 subtype","volume":"16","author":"Wong","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189559_bib634","first-page":"117","article-title":"PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer","volume":"23","author":"Li","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbcan.2026.189559_bib635","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2016.11.018","article-title":"Doxorubicin-induced mitophagy contributes to drug resistance in cancer stem cells from HCT8 colorectal cancer cells","volume":"388","author":"Yan","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189559_bb0205","doi-asserted-by":"crossref","first-page":"511","DOI":"10.5966\/sctm.2015-0214","article-title":"Cancer stem cell-based models of colorectal Cancer reveal molecular determinants of therapy resistance","volume":"5","author":"De Angelis","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189559_bb0210","article-title":"RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescence, iScience","volume":"24","author":"Regan","year":"2021"},{"key":"10.1016\/j.bbcan.2026.189559_bb0215","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.stemcr.2017.06.002","article-title":"RBP4-STRA6 pathway drives cancer stem cell maintenance and mediates high-fat diet-induced colon carcinogenesis","volume":"9","author":"Karunanithi","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189559_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110658","article-title":"The SW480 cell line as a model of resident and migrating colon cancer stem cells","volume":"27","author":"Verhagen","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.bbcan.2026.189559_bb0225","article-title":"Lars2-signaling mediates platinum resistance by accumulating cancer stem cell population and suppressing anti-tumor immunity","volume":"85","author":"Wang","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2026.189559_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167993","article-title":"Hypoxia facilitates stemness of colon cancer cells via histone lactylation","volume":"1871","author":"Zhang","year":"2025","journal-title":"BBA-Mol. Basis Dis."},{"key":"10.1016\/j.bbcan.2026.189559_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114866","article-title":"Tumor cell exosome circ-0023919 promotes EMT through the miR-197-5p\/ICAM5 axis and enhances the drug resistance of colorectal cancer to 5-fu","volume":"455","author":"Zhang","year":"2026","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbcan.2026.189559_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217917","article-title":"Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer","volume":"631","author":"He","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189559_bb0245","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1021\/acs.molpharmaceut.4c00264","article-title":"Lipopolysaccharide induces resistance to CAR-T cell therapy of colorectal Cancer cells through TGF-\u03b2-mediated stemness enhancement","volume":"22","author":"Tao","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbcan.2026.189559_bb0250","article-title":"Assessment of drug treatment response using primary human colon cancer cell spheroids cultivated in a microfluidic mixer chip","volume":"69","author":"Zhou","year":"2025","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.bbcan.2026.189559_bb0255","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/j.celrep.2017.11.025","article-title":"Non-canonical hedgehog signaling is a positive regulator of the WNT pathway and is required for the survival of colon cancer stem cells","volume":"21","author":"Regan","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189559_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112324","article-title":"Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer","volume":"42","author":"Mertens","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189559_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107116","article-title":"Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer","volume":"26","author":"Tang","year":"2023","journal-title":"Iscience"},{"key":"10.1016\/j.bbcan.2026.189559_bb0270","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1158\/1078-0432.CCR-17-2151","article-title":"A molecularly annotated model of patient-derived colon cancer stem\u2013like cells to assess genetic and nongenetic mechanisms of resistance to anti-EGFR therapy","volume":"24","author":"Luraghi","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189559_bb0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2026.189559_bb0280","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/cancers13061205","article-title":"Dual inhibition of AKT and MEK pathways potentiates the anti-cancer effect of gefitinib in triple-negative breast cancer cells","volume":"13","author":"You","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189559_bb0285","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4199052","article-title":"AT7867 inhibits the growth of colorectal cancer stem-like cells and stemness by regulating the stem cell maintenance factor Ascl2 and Akt signaling","volume":"2023","author":"Li","year":"2023","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.bbcan.2026.189559_bb0290","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/acsptsci.1c00257","article-title":"Therapeutic targeting of cancer stem cells prevents resistance of colorectal cancer cells to MEK inhibition","volume":"5","author":"Lamichhane","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bbcan.2026.189559_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116842","article-title":"Basroparib overcomes acquired resistance to MEK inhibitors by inhibiting Wnt-mediated cancer stemness in KRAS-mutated colorectal cancer","volume":"235","author":"Kwon","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0300","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12032-022-01851-4","article-title":"Morin inhibits colon cancer stem cells by inhibiting PUM1 expression in vitro","volume":"39","author":"Gor","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.3959","article-title":"Kurarinone targets JAK2-STAT3 signaling in colon cancer-stem-like cells","volume":"42","author":"Prajapati","year":"2024","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bbcan.2026.189559_bb0310","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1080\/01635581.2021.1933098","article-title":"Some bryophytes trigger cytotoxicity of stem cell-like population in 5-fluorouracil resistant colon cancer cells","volume":"74","author":"Ozerkan","year":"2022","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.bbcan.2026.189559_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106991","article-title":"Curcumin may be a potential adjuvant treatment drug for colon cancer by targeting CD44","volume":"88","author":"Fan","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112612","article-title":"Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticles","volume":"217","author":"Lazer","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbcan.2026.189559_bb0325","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.stemcr.2022.02.005","article-title":"Niclosamide induces miR-148a to inhibit PXR and sensitize colon cancer stem cells to chemotherapy","volume":"17","author":"Bansard","year":"2022","journal-title":"Stem Cell Reports."},{"key":"10.1016\/j.bbcan.2026.189559_bb0330","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12519","article-title":"Melatonin and 5-fluorouracil co-suppress colon cancer stem cells by regulating cellular prion protein-Oct4 axis","volume":"65","author":"Lee","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bbcan.2026.189559_bb0335","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxlet.2020.02.002","article-title":"DNA damage in colon mucosa of Pirc rats, an Apc-driven model of colon tumorigenesis","volume":"324","author":"Tortora","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbcan.2026.189559_bb0340","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.3390\/cancers13236045","article-title":"Oxidative distress induces Wnt\/\u03b2-catenin pathway modulation in colorectal cancer cells: perspectives on APC retained functions","volume":"13","author":"Catalano","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189559_bb0345","article-title":"Genomic alterations in the WNT\/\u03b2-catenin pathway and resistance of colorectal cancer cells to pathway-targeting therapies","volume":"6","author":"Voutsadakis","year":"2025","journal-title":"Explor. Target Antitumor. Ther."},{"key":"10.1016\/j.bbcan.2026.189559_bb0350","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41417-025-00935-3","article-title":"Rapamycin rescues APC-mutated colon organoid differentiation","volume":"32","author":"Habib","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbcan.2026.189559_bb0355","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.isci.2020.101795","article-title":"Epigenetic regulation of Wnt signaling by carboxamide-substituted benzhydryl amines that function as histone demethylase inhibitors","volume":"23","author":"Zhang","year":"2020","journal-title":"Iscience"},{"key":"10.1016\/j.bbcan.2026.189559_bb0360","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ccell.2015.11.001","article-title":"HOXA5 counteracts stem cell traits by inhibiting Wnt signaling in colorectal cancer","volume":"28","author":"Ordonez-Mor\u00e1n","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189559_bb0365","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.ymthe.2019.06.013","article-title":"The delivery of a Wnt pathway inhibitor toward CSCs requires stable liposome encapsulation and delayed drug release in tumor tissues","volume":"27","author":"Li","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbcan.2026.189559_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110319","article-title":"Liquidambaric acid inhibits Wnt\/\u03b2-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2","volume":"38","author":"Yan","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189559_bb0375","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jcyt.2017.09.009","article-title":"Adoptive transfer of natural killer cells in combination with chemotherapy improves outcomes of patients with locally advanced colon carcinoma","volume":"20","author":"Li","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbcan.2026.189559_bb0380","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/0284186X.2016.1201215","article-title":"LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer","volume":"55","author":"Stanisavljevic","year":"2016","journal-title":"Acta Oncol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0385","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41392-024-01788-2","volume":"9","author":"Pan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189559_bb0390","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jama.2021.2454","article-title":"Effect of celecoxib vs placebo added to standard adjuvant therapy on disease-free survival among patients with stage III colon cancer: the CALGB\/SWOG 80702 (Alliance) randomized clinical trial","volume":"325","author":"Meyerhardt","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.bbcan.2026.189559_bb0395","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jjco\/hyab183","article-title":"Preoperative and postoperative prognostic factors of patients with stage II\/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212)","volume":"52","author":"Ohue","year":"2022","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0400","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/cam4.3630","article-title":"A phase 2 trial of trifluridine\/tipiracil plus nivolumab in patients with heavily pretreated microsatellite-stable metastatic colorectal cancer","volume":"10","author":"Patel","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2026.189559_bb0405","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.ccell.2025.08.002","article-title":"Phase 1\/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer","volume":"43","author":"Morris","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189559_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169399","article-title":"TargetPair: a single cell-omics resource of clinical trials-derived therapeutical target combinations for cancer therapy","volume":"437","author":"Zhou","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0415","article-title":"Prognostic value of circulating tumor DNA for recurrence risk in stage III colorectal cancer: a systematic review and meta-analysis","author":"Aliyeva","year":"2025","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.bbcan.2026.189559_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115388","article-title":"FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: refining first-line treatment selection by combining clinical parameters: a post hoc analysis of the randomized open-label phase III trial FIRE-3\/AIO KRK0306","volume":"220","author":"Holch","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189559_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106081","article-title":"Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases","volume":"123","author":"Crnovrsanin","year":"2026","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbcan.2026.189559_bb0430","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.annonc.2024.12.013","article-title":"Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population\u2606","volume":"36","author":"Seligmann","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0435","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(25)00083-X","article-title":"Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-Centre, phase 1 trial","volume":"26","author":"Lou","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0440","article-title":"The PRL3-zumab paradigm: a multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy","volume":"6","author":"Park","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbcan.2026.189559_bb0445","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2019.37.4_suppl.482","article-title":"Adjuvant HIPEC in patients with colon cancer at high risk of peritoneal metastases: primary outcome of the COLOPEC multicenter randomized trial","volume":"37","author":"Klaver","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0450","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/1078-0432.CCR-19-1209","article-title":"Disease monitoring using post-induction circulating tumor DNA analysis following first-line therapy in patients with metastatic colorectal cancer","volume":"26","author":"Ma","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189559_bb0455","first-page":"215","article-title":"Genomic instability and therapeutic targeting of DNA\/RNA pathways in colorectal cancer stem cells","volume":"18","author":"Yue","year":"2023","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189559_bb0460","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s12276-021-00557-3","article-title":"Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189559_bb0465","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12943-015-0372-7","article-title":"miR-21 and miR-145 cooperation in regulation of colon cancer stem cells","volume":"14","author":"Yu","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2026.189559_bb0470","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1158\/0008-5472.CAN-10-4645","article-title":"MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma","volume":"71","author":"Ibrahim","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189559_bb0475","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2026.189559_bb0480","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s12094-020-02464-x","article-title":"Oxymatrine reduces expression of programmed death-ligand 1 by promoting DNA demethylation in colorectal cancer cells","volume":"23","author":"Hua","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0485","article-title":"LncRNA in gastric cancer drug resistance: deciphering the therapeutic strategies","volume":"15","author":"Liu","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0490","doi-asserted-by":"crossref","first-page":"11711","DOI":"10.2147\/OTT.S277254","article-title":"The SP1-induced long noncoding RNA, LINC00339, promotes tumorigenesis in colorectal cancer via the miR-378a-3p\/MED19 axis","volume":"13","author":"Ye","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bbcan.2026.189559_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112714","article-title":"Aptamer-conjugated nanoliposomes containing COL1A1 siRNA sensitize CRC cells to conventional chemotherapeutic drugs","volume":"218","author":"Manoochehri","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbcan.2026.189559_bb0500","article-title":"CRISPR\/Cas9 and Cas13 technologies for targeting non-coding RNAs in cancer","volume":"8","author":"Chakrabarti","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbcan.2026.189559_bb0505","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12935-021-01800-7","article-title":"ABCB1 and ABCG2 restricts the efficacy of gedatolisib (PF-05212384), a PI3K inhibitor in colorectal cancer cells","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2026.189559_bb0510","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12943-020-01240-3","article-title":"CircRNAs in anticancer drug resistance: recent advances and future potential","volume":"19","author":"Xu","year":"2020","journal-title":"Molecul. Cancer"},{"key":"10.1016\/j.bbcan.2026.189559_bb0515","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3390\/cancers14061388","article-title":"Targeting the DNA damage response pathway as a novel therapeutic strategy in colorectal cancer","volume":"14","author":"Catalano","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189559_bb0520","first-page":"1896","article-title":"miR-4711-5p suppresses colorectal cancer stem cell traits via KLF5\/TFDP1\/MDM2 axis","volume":"11","author":"Morimoto","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189559_bb0525","article-title":"MSC-derived exosomes carrying miR-125b-5p enhance anti-PD-1 efficacy and colorectal cancer stem cell clearance","volume":"17","author":"Jiang","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189559_bb0530","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13046-022-02403-4","article-title":"The interplay between noncoding RNA and YAP\/TAZ signaling in cancers: molecular functions and mechanisms","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189559_bb0535","doi-asserted-by":"crossref","first-page":"14861","DOI":"10.1038\/s41598-019-50968-6","article-title":"CD44\/CD133-positive colorectal cancer stem cells are sensitive to trifluridine exposure","volume":"9","author":"Tsunekuni","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189559_bb0540","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3892\/ol.2017.6415","article-title":"Differential expression profile analysis of DNA damage repair genes in CD133+\/CD133- colorectal cancer cells","volume":"14","author":"Lu","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2026.189559_bb0545","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41419-019-2057-4","article-title":"Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon","volume":"10","author":"Burocziova","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189559_bb0550","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126853","article-title":"Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy","volume":"4","author":"Sun","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2026.189559_bb0565","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s13277-015-4477-9","article-title":"The immunobiology of myeloid-derived suppressor cells in cancer","volume":"37","author":"Motallebnezhad","year":"2016","journal-title":"Tumour Biol."},{"issue":"22","key":"10.1016\/j.bbcan.2026.189559_bb0570","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.7150\/jca.62123","article-title":"Synergistic killing effects of PD-L1-CAR T cells and colorectal cancer stem cell-dendritic cell vaccine-sensitized T cells in ALDH1-positive colorectal cancer stem cells","volume":"12","author":"Liu","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189559_bb0575","article-title":"Lipid nanoparticle-mediated IL-2 delivery for cancer immunotherapy","volume":"245","author":"Li","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbcan.2026.189559_bb0580","first-page":"568","article-title":"Hypoxia-activated prodrugs synergize with immunotherapy in colorectal cancer","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189559_bb0585","first-page":"1244","article-title":"Clinical efficacy of PD1-T combined with XELOX and bevacizumab in metastatic colorectal cancer","volume":"13","author":"Pan","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2026.189559_bb0590","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jcyt.2023.01.009","article-title":"Generation of colon cancer\u2013derived tumor-infiltrating T cells for adoptive cell therapy","volume":"25","author":"Albrecht","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbcan.2026.189559_bb0615","first-page":"1456","article-title":"An adoptive T cell immunotherapy targeting cancer stem cells in a colon cancer model","volume":"20","author":"Gao","year":"2015","journal-title":"JBUON"},{"key":"10.1016\/j.bbcan.2026.189559_bb0600","doi-asserted-by":"crossref","first-page":"16868","DOI":"10.18632\/oncotarget.16868","article-title":"Radioimmunotherapy for CD133(+) colonic cancer stem cells inhibits tumor development in nude mice","volume":"8","author":"Dinghu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189559_bb0605","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1158\/1535-7163.MCT-17-1086","article-title":"Development of MGD007, a gpA33 x CD3 bispecific DART\u00ae protein for T-cell immunotherapy of metastatic colorectal cancer","volume":"17","author":"Moore","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2026.189559_bb0610","first-page":"2963","article-title":"OR7C1 is a novel cancer-testis antigen capable of eliciting spontaneous immune responses in colorectal cancer patients","volume":"22","author":"Morita","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189559_bb0620","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189559_bb0625","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T08:36:15Z","timestamp":1782030975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":134,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0304419X26000314"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189559","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colorectal cancer stem cells in the tumor microenvironmental niche: Mechanistic insights and emerging therapies","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189559"}}